263 related articles for article (PubMed ID: 27130369)
1. Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex Trial.
Campochiaro PA; Hafiz G; Mir TA; Scott AW; Zimmer-Galler I; Shah SM; Wenick AS; Brady CJ; Han I; He L; Channa R; Poon D; Meyerle C; Aronow MB; Sodhi A; Handa JT; Kherani S; Han Y; Sophie R; Wang G; Qian J
Am J Ophthalmol; 2016 Aug; 168():13-23. PubMed ID: 27130369
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
Totan Y; Güler E; Gürağaç FB
Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
[TBL] [Abstract][Full Text] [Related]
3. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
Sohn HJ; Han DH; Kim IT; Oh IK; Kim KH; Lee DY; Nam DH
Am J Ophthalmol; 2011 Oct; 152(4):686-94. PubMed ID: 21782151
[TBL] [Abstract][Full Text] [Related]
4. Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema.
Hillier RJ; Ojaimi E; Wong DT; Mak MYK; Berger AR; Kohly RP; Kertes PJ; Forooghian F; Boyd SR; Eng K; Altomare F; Giavedoni LR; Nisenbaum R; Muni RH
JAMA Ophthalmol; 2018 Apr; 136(4):382-388. PubMed ID: 29522144
[TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
[TBL] [Abstract][Full Text] [Related]
6. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
[TBL] [Abstract][Full Text] [Related]
7. Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema.
Podkowinski D; Orlowski-Wimmer E; Zlabinger G; Pollreisz A; Mursch-Edlmayr AS; Mariacher S; Ring M; Bolz M
Acta Ophthalmol; 2020 Jun; 98(4):e407-e415. PubMed ID: 31736269
[TBL] [Abstract][Full Text] [Related]
8. Anti-VEGF versus dexamethasone implant (Ozurdex) for the management of Centre involved Diabetic Macular Edema (CiDME): a randomized study.
Sharma A; Bellala K; Dongre P; Reddy P
Int Ophthalmol; 2020 Jan; 40(1):67-72. PubMed ID: 31377905
[TBL] [Abstract][Full Text] [Related]
9. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
Yu SY; Nam DH; Lee DY
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):39-47. PubMed ID: 29030692
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema.
Güler E; Totan Y; Betül Güragaç F
Cutan Ocul Toxicol; 2017 Jun; 36(2):180-184. PubMed ID: 28366074
[TBL] [Abstract][Full Text] [Related]
11. The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX Trial.
Mehta H; Fraser-Bell S; Nguyen V; Lim LL; Gillies MC
Ophthalmol Retina; 2018 Mar; 2(3):231-234. PubMed ID: 31047591
[TBL] [Abstract][Full Text] [Related]
12. Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) Study.
Campochiaro PA; Hafiz G; Mir TA; Scott AW; Sophie R; Shah SM; Ying HS; Lu L; Chen C; Campbell JP; Kherani S; Zimmer-Galler I; Wenick A; Han I; Paulus Y; Sodhi A; Wang G; Qian J
Am J Ophthalmol; 2015 Aug; 160(2):313-321.e19. PubMed ID: 25908486
[TBL] [Abstract][Full Text] [Related]
13. Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
Hwang HS; Chae JB; Kim JY; Kim DY
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5958-5967. PubMed ID: 29183041
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
15. Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema.
Aroney C; Fraser-Bell S; Lamoureux EL; Gillies MC; Lim LL; Fenwick EK
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5541-5546. PubMed ID: 27768792
[TBL] [Abstract][Full Text] [Related]
16. Behavior of SD-OCT Detectable Hyperreflective Foci in Diabetic Macular Edema Patients after Therapy with Anti-VEGF Agents and Dexamethasone Implants.
Rübsam A; Wernecke L; Rau S; Pohlmann D; Müller B; Zeitz O; Joussen AM
J Diabetes Res; 2021; 2021():8820216. PubMed ID: 33937416
[TBL] [Abstract][Full Text] [Related]
17. Persistent or Recurrent Diabetic Macular Edema After Fluocinolone Acetonide 0.19 mg Implant: Risk Factors and Management.
Cicinelli MV; Rabiolo A; Zollet P; Capone L; Lattanzio R; Bandello F
Am J Ophthalmol; 2020 Jul; 215():14-24. PubMed ID: 32209341
[TBL] [Abstract][Full Text] [Related]
18. Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.
Figueras-Roca M; Sala-Puigdollers A; Alforja S; Torras J; Peraza-Nieves J; Zarranz-Ventura J; Adan Civera A; Molins B
Ocul Immunol Inflamm; 2019; 27(8):1203-1210. PubMed ID: 31418610
[No Abstract] [Full Text] [Related]
19. Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy.
Hussain RM; Ciulla TA
Expert Opin Biol Ther; 2016; 16(3):365-74. PubMed ID: 26674182
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial.
Mehta H; Fraser-Bell S; Yeung A; Campain A; Lim LL; Quin GJ; McAllister IL; Keane PA; Gillies MC
Br J Ophthalmol; 2016 Jul; 100(7):1000-1004. PubMed ID: 26537156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
